This week Ampleforth (AMPLBTC) broke weekly above a new resistance to hit its highest price/level since October 2020.
A long-term double bottom pattern was formed for this pair in 2021 followed by a very strong bull-market.
AMPLBTCs bull market is reaching its climax.
From its Nov. 2021 low, so far we have over 760% of growth.
Additional resistance levels are mapped on the chart.
We are not making any predictions here, just sharing what has been happening with this pair.
Thank you for reading.
Namaste.
A long-term double bottom pattern was formed for this pair in 2021 followed by a very strong bull-market.
AMPLBTCs bull market is reaching its climax.
From its Nov. 2021 low, so far we have over 760% of growth.
Additional resistance levels are mapped on the chart.
We are not making any predictions here, just sharing what has been happening with this pair.
Thank you for reading.
Namaste.
🚨 TOP FREE Trades
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
🚨 TOP FREE Trades
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.